SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer

被引：0
|
作者：
Tabbo, Fabrizio [1 ]
Reale, Maria Lucia [1 ]
Ruffini, Enrico [2 ]
Novello, Silvia [1 ]
Guerrera, Francesco [2 ]
机构：
[1] Univ Torino, Dept Oncol, Turin, Italy
[2] Univ Torino, Dept Surg Sci, Turin, Italy
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2019年 / 7卷 / 09期
关键词：
TYROSINE KINASE INHIBITORS; ERLOTINIB; PLACEBO;
D O I：
10.21037/atm.2019.03.55
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Epidermal Growth Factor Receptor Inhibitors and Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer
    Horn, Leora
    Sandler, Alan
    CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5040 - 5048
  • [32] Tumor Epidermal Growth Factor Receptor Genotype and Depression in Stage IV Non-Small Cell Lung Cancer
    Pirl, William F.
    Traeger, Lara
    Greer, Joseph A.
    Bemis, Heather
    Gallagher, Emily
    Lennes, Inga
    Sequist, Lecia
    Heist, Rebecca
    Temel, Jennifer S.
    ONCOLOGIST, 2011, 16 (09): : 1299 - 1306
  • [33] Efficacy and safety of almonertinib in the adjuvant treatment of resectable stage I non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR)-sensitizing mutations in solid and/or micropapillary components
    Han, B.
    Fang, V.
    Yao, F.
    Song, P.
    Yue, D.
    Qi, Y.
    Zhang, B.
    Zhang, W.
    Zhang, Y.
    Tan, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S981 - S981
  • [34] Epidermal growth factor receptor mutations in patients with non-small cell lung cancer
    Johnson, BE
    Jänne, PA
    CANCER RESEARCH, 2005, 65 (17) : 7525 - 7529
  • [35] Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Zhou, Yongchun
    Yang, Yanlong
    Yang, Chenggang
    Chen, Yunlan
    Yang, Changshao
    Du, Yaxi
    Zhao, Guangqiang
    Guo, Yinjin
    Ye, Lianhua
    Huang, Yunchao
    ONCOTARGET, 2017, 8 (09) : 15023 - 15033
  • [36] Inhibition of epidermal growth factor receptor pathway by epidermal growth factor antibodies in non-small cell lung cancer
    Codony-Servat, Jordi
    -Vila, Miguel Angel Molina
    Bertran-Alamillo, Jordi
    Rosell, Rafael
    D'Hondt, Erik
    CANCER RESEARCH, 2016, 76
  • [37] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION ANALYSIS IN NON-SMALL CELL LUNG CANCER (NSCLC) IN AN IRISH POPULATION
    Graham, Donna M.
    O'Connor, Kate
    Teo, Min Y.
    Burke, Louise
    Mccarthy, Julie
    O'Dea, Pauline
    O'Keefe, Margaret
    Moylan, Eugene J.
    Power, Derek G.
    O'Reilly, Seamus
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1527 - S1528
  • [38] Update on epidermal growth factor receptor mutations in non-small cell lung cancer
    Riely, Gregory J.
    Politi, Katerina A.
    Miller, Vincent A.
    Pao, William
    CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7232 - 7241
  • [39] Epidermal Growth Factor Receptor Status in Stages of Resected Non-Small Cell Lung Cancer Implications for Treatment with Epidermal Growth Factor Receptor Inhibitors
    Berardi, Rossana
    Santinelli, Alfredo
    Brunelli, Alessandro
    Onofri, Azzurra
    Pierantoni, Chiara
    Scartozzi, Mario
    Pisa, Eleonora
    Stramazzotti, Daniela
    Mazzanti, Paola
    Zuccatosta, Lina
    Gasparini, Stefano
    Sabbatini, Armando
    Cascinu, Stefano
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2011, 33 (04): : 196 - 204
  • [40] Prevalence of epidermal growth factor receptor (EGFR) mutation in an Ecuadorian population with non-small cell lung cancer (NSCLC).
    Rivas, Carmen
    Martinez, Luis A.
    Eduardo Teran, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345